OFFICIAL LEGAL TITLE
Defense Biotechnology Strategy Act
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 119_HR_6009.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2025-11-10.
What are the main provisions?
Key points include:
- Securing Supply Chains: DoD must establish a network of commercial facilities for biomanufacturing products critical for defense needs, supporting domestic industry.
- International Cooperation: The strategy includes plans for coordinating research and pooling purchasing power for biotech products among NATO member countries, increasing spending efficiency.
- Modernizing Defense: Military specifications will be reviewed to incorporate or substitute existing products with advanced biotechnology solutions and utilize them in war games and strategic analyses.
What is the specific legal status?
The current status is Introduced.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. Houlahan, Chrissy [D-PA-6].
What is the latest detailed status?
The latest detailed status is: Introduced in House
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.
What is the impact of this bill?
We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.